The global home infusion therapy market size was USD 41.36 billion in 2020. The market is projected to grow from USD 34.54 billion in 2021 to USD 54.82 billion in 2028, with a CAGR of 6.8% in the 2021-2028 period.
Fortune Business Insights just published the Home Infusion Therapy Market Report, which assesses the industry in terms of market size, market share, revenue estimation, and geographical perspective. The study also provides a thorough summary of the Home Infusion Therapy Market's competitive, growth possibilities, and application landscape based on the industry's financial and non-financial effects. The entire range of information related to the Global Home Infusion Therapy Market is obtained from various sources, and the obtained bulk of the information is arranged, processed, and represented by a group of specialists using various methodological techniques and analytical tools such as SWOT analysis to generate a comprehensive set of trade-based studies.
Request a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/102989
Market Drivers:
- Regulations by the Centres for Medicare & Medicaid Services (CMC) allowed virtual patient visits, which may slightly hinder the uptake of home infusion therapy.
- Rising prevalence of chronic diseases and a growing geriatric population are fueling demand for home infusion therapy.
- The absence of reimbursement policies in some developing countries is a restraining factor.
Competitive Analysis:
The leading businesses are concentrating heavily on production technology innovation to boost efficiency and shelf life. Long-term growth potential in this sector can be realized by assuring continuous process improvements and financial flexibility to invest in effective methods. Some of the participants include
- Option Care Health Inc. (Illinois, U.S.)
- Optum, Inc. (Minnesota, U.S.)
- CareCentrix, Inc. (Hartford, U.S.)
- Lincare Holdings Inc. (Florida, U.S.)
- BriovaRx Infusion Services (Houston, U.S.)
- Fresenius SE & Co. KGaA (Bad Homburg, Germany)
- Baxter International (Deerfield, Illinois, U.S.)
- B. Braun Melsungen AG (Melsungen, Germany)
- Terumo Corporation (Tokyo, Japan)
- Moog Inc. (New York, U.S.)
Speak to the Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/102989
Key Highlights:
- COVID-19 positively impacted the demand for home-care therapy globally.
- The market showed a remarkable growth of 51.8% in 2020 compared to the average year-on-year growth during 2017-2019.
- The rise in preference for homecare, particularly for infusion treatment, and the development of infusion healing devices for home use are key factors driving market growth.
- The pandemic led to an increase in the number of patients receiving infusion therapy at home.
- The market is segmented into devices, drugs, and services, with the drug segment holding the largest market share in 2020.
- North America led the market in 2020, while Asia Pacific is expected to witness the highest growth during the forecast period.
- Key industry players include Option Care Health Inc., Optum, Inc., CareCentrix, Inc., CVS Health, and more.
- Companies are focusing on expanding their geographical footprints, introducing new services, and collaborating to provide access to patients.
The industry report covers the following data points:
Section 1: This section provides an overview of the global Home Infusion Therapy Market, including a general market introduction, market analysis by applications, type, and geography. North America, Europe, Asia-Pacific, and the Middle East and Africa are the primary regions of the worldwide Home Infusion Therapy Market business. This section contains information and forecasts for the Home Infusion Therapy Market (2022-2028). Market dynamics describe the potential, primary driving forces, and market risk.
Section 2: This section provides a profile of the Market manufacturer based on their business overview, product type, and application. This study also profiles each player's sales volume, market product price, gross margin analysis, and market share.
Sections 3 and 4: These sections present the market rivalry based on each manufacturer's sales, profitability, and market division. It also discusses the industry scenario in terms of regional conditions.
Sections 5 and 6: These sections give forecast data for the Home Infusion Therapy Market (2022-2028) by region. This research presents sales channels such as direct and indirect marketing, traders, distributors, and development patterns.
Sections 7 and 8: These sections address the industry's important study results and outcomes, analysis technique, and data sources.
Buy this Research report: https://www.fortunebusinessinsights.com/checkout-page/102989
Related Reports:
Serum-Free Light Chain Assays Market
Acquisition of the market for therapeutics for rare blood diseases
Intensive care therapeutics market
About us:
Fortune Business Insights™ provides accurate data and innovative enterprise analytics to help organizations of all sizes make better decisions. We tailor novel solutions for our clients to help them meet a variety of unique business challenges. Our aim is to provide a detailed overview of the markets in which they operate to provide holistic market intelligence.
Address:
Fortune Business Insights Pvt.
9th Floor, Icon Tower, Baner –
Pune-411045,
India, Maharashtra.
Telephone:
USA: +1 424 253 0390
UK: +44 2071 939123
Asia Pacific: +91 744 740 1245
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)